Sign Up to like & get recommendations! 0
Published in 2017 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.26908
Abstract: Clinical outcomes and adverse events utilizing the large volume 50cc intra‐aortic balloon (IAB) in contemporary clinical practice. read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.30197
Abstract: In contemporary Cardiac Intensive Care Unit (CICU), bedside intra‐aortic balloon pump (IABP) insertion under echocardiographic guidance may be an attractive option for selected patients with cardiogenic shock (CS). Currently available data on this approach are… read more here.
Sign Up to like & get recommendations! 1
Published in 2020 at "ESC Heart Failure"
DOI: 10.1002/ehf2.12721
Abstract: Intra‐aortic balloon pump (IABP) utilization was expected to be quickly abandoned following the IABP‐shock trial and its class III, level B recommendation in the 2016 European Society of Cardiology (ESC) guidelines. The aim of this… read more here.
Sign Up to like & get recommendations! 1
Published in 2021 at "ESC Heart Failure"
DOI: 10.1002/ehf2.13479
Abstract: The real‐world usage of intra‐aortic balloon pump (IABP) in various cardiogenic shocks (CS) and the association with outcomes are lacking. We aimed to investigate IABP adoption in CS in a nationwide registry in China. read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "ESC Heart Failure"
DOI: 10.1002/ehf2.13981
Abstract: To investigate the impact of intra‐aortic balloon pump (IABP) on the regional haemodynamics of patients with severe cardiogenic shock undergoing femoro‐femoral veno‐arterial extracorporeal membrane oxygenation (VA‐ECMO). read more here.
Sign Up to like & get recommendations! 1
Published in 2018 at "Journal of the American College of Cardiology"
DOI: 10.1016/j.jacc.2018.08.1175
Abstract: Despite increasing use and expanding indications for the Impella (ABIOMED, Danvers, MA) heart pump, there are limited data supporting its benefit compared with intra-aortic balloon pump (IABP) support in patients undergoing percutaneous coronary intervention (PCI).… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "Medicina intensiva"
DOI: 10.1016/j.medin.2016.06.009
Abstract: OBJECTIVE To analyze the use and impact of the intra-aortic balloon pump (IABP) upon the 30-day mortality rate and short-term clinical outcome of non-selected patients with ST-elevation acute myocardial infarction (acute STEMI) complicated by cardiogenic… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Progress in cardiovascular diseases"
DOI: 10.1016/j.pcad.2020.07.001
Abstract: The intra-aortic balloon pump (IABP) has been in routine use for various cardiovascular indications for 5 decades. However, its regular use has been increasingly questioned. The aim of IABP counterpulsation is to enhance coronary blood… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "Journal of the American College of Cardiology"
DOI: 10.1016/s0735-1097(17)34249-3
Abstract: Background: Temporary mechanical support may be necessary in patients with myocarditis. Our study describes the outcomes of intra-aortic balloon pump (IABP) use in patients with myocarditis complicated with cardiogenic shock. Methods: We identified patients with… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "Journal of the American College of Cardiology"
DOI: 10.1016/s0735-1097(17)34578-3
Abstract: Background: Due to the high mortality rate, the therapy of patients (PTS) with an acute coronary syndrome (ACS) and cardiogenic shock (CS) remains still a challenge. Over many years we used an intra-aortic balloon pump… read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "Journal of the American College of Cardiology"
DOI: 10.1016/s0735-1097(18)31756-x
Abstract: Percutaneous ventricular assist devices (PVAD) and intra-aortic balloon pump (IABP) provide mechanical support for patients in cardiogenic shock (CS). However, comparative outcomes of these therapies in a large real-world study remains unclear. Data was obtained… read more here.